The Michigan Department of Community Health, Newborn Screening Follow-up Program assures that all newborns are screened and that infants with positive tests receive confirmatory diagnosis and treatment. For more information about newborn screening in Michigan, including updates for hospitals and information for parents, please visit www.michigan.gov/newbornscreening.

As of April 2005, newborn babies in Michigan are screened for 40 rare but treatable disorders as well as hearing loss. State law requires that a dried blood spot specimen on every newborn be sent to the state laboratory for screening. Some of the disorders include: 

1. Biotinidase Deficiency pdf 174 kb
2. Congenital Adrenal Hyperplasia (CAH) pdf 174 kb
3. Congenital Hypothyroidism pdf 149 kb
4. Cystic Fibrosis pdf 27kb
5. Galactosemia pdf 173 kb
6. Hemoglobinopathies (Sickle Cell) pdf 174 kb
7. Maple Syrup Urine Disease (MSUD) pdf 173 kb
8. Medium Chain Acyl-CoA Dehydrogenase Deficiency (MCAD) pdf 174 kb
9. Phenylketonuria (PKU) pdf 174 kb

Clinical diagnosis and treatment services for infants identified by newborn screening are provided by three medical management centers:

• Sickle Cell Disease Association, Michigan Chapter
• University of Michigan Endocrinology
• Children's Hospital of Michigan - Metabolic Clinic

• ENGLISH version,   
• ARABIC version
• SPANISH version    
• OR order pamphlets.
  

The Region 4 Genetics Collaborative announces the availability of  Newborn Screening: What Prenatal Caregivers Need to Know.  This self-paced, on-line educational module is accessible free of charge to all health care professionals and providers involved in the care of new and expectant mothers.  Free CEUs are also available!


EXPANDED NEWBORN SCREENING: CHANGING THE FACE OF 
INBORN ERRORS OF METABOLISM  
An educational webcast for physicians and health care professional 
click here to view the webcast

 



• Other national websites that might be of interest:
       Genes-R-Us
       Texas NBS
       Washington State Health Dept.